Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Pharmacy and Science

• Publication date

  2002-03-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1002/JPS.10063PMID 11920765
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability.

  2001cited by this paper
• Antisense oligonucleotides: promise and reality.

  2001cited by this paper
• Liposome-based formulations for the delivery of oligonucleotides

  2001cited by this paper
• Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres.

  2000cited by this paper
• Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres.

  2000cited by this paper
• Cellular delivery of antisense oligonucleotides.

  2000cited by this paper
• Sensible use of antisense: how to use oligonucleotides as research tools.

  2000cited by this paper
• Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique

  2000cited by this paper
• Optimisation of polyethylenimine-based gene delivery to mouse brain.

  1999cited by this paper
• Poly(ethylenimine) and its role in gene delivery.

  1999cited by this paper
• A Polysorbate-Based Non-Ionic Surfactant Can Modulate Loading and Release of β-Lactoglobulin Entrapped in Multiphase Poly(DL-Lactide-co-glycolide) Microspheres

  1999cited by this paper
• Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides.

  1999cited by this paper
• A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides.

  1999cited by this paper
• Gene transfer with lipospermines and polyethylenimines.

  1998cited by this paper
• Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.

  1998cited by this paper
• Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold.

  1996cited by this paper
• A Powerful Nonviral Vector for In Vivo Gene Transfer into the Adult Mammalian Brain: Polyethylenimine

  1996cited by this paper
• Preparation of porous and nonporous biodegradable polymeric hollow microspheres

  1995cited by this paper
• A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

  1995cited by this paper
• Biodegradable poly(L-lactic acid) matrices for the sustained delivery of antisense oligonucleotides

  1995cited by this paper
• Effect of the emulsion stability on the morphology and porosity of semicrystalline poly l-lactide microparticles prepared by w/o/w double emulsion-evaporation

  1994cited by this paper
• Polyamidoamine cascade polymers mediate efficient transfection of cells in culture.

  1993cited by this paper
• The Preparation and Characterization of Poly(lactide-co-glycolide) Microparticles. II. The Entrapment of a Model Protein Using a (Water-in-Oil)-in-Water Emulsion Solvent Evaporation Technique

  1993cited by this paper
• Cellular uptake and intracellular fate of antisense oligonucleotides.

  1992cited by this paper
• Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.

  1991cited by this paper
• Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera.

  1991cited by this paper
• Intracellular distribution of microinjected antisense oligonucleotides.

  1991cited by this paper
• Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA.

  1989cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Stabilization of water/oil/water multiple emulsions by polymerization of the aqueous phases

  1982cited by this paper
• Pharmacokinetics , biodistribution , and stability of oligodeoxynucleotide phosphorothioates in mice ( antisense inhibition of gene expression / antiviral therapy / oligodeoxynucleotide uptake / human inimunodeficiency virus )

  year unknowncited by this paper

• Advanced nanotechnology in enhancing immune checkpoint inhibitors (ICIs) for head and neck cancer therapy

  2025cites this paper
• Synthetic-polymer-assisted antisense oligonucleotide delivery: targeted approaches for precision disease treatment

  2025cites this paper
• Injectable Hydrogel Microspheres for Sustained Gene Delivery of Antisense Oligonucleotides to Restore the Expression of Dystrophin Protein in Duchenne Muscular Dystrophy

  2022cites this paper
• Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases.

  2021cites this paper
• Combining dexamethasone and TNF-α siRNA within the same nanoparticles to enhance anti-inflammatory effect.

  2021cites this paper
• PLGA/PCADK Composite Microspheres Containing Hyaluronic Acid-Chitosan siRNA Nanoparticles: A Rational Design for Rheumatoid Arthritis Therapy.

  2021cites this paper
• Nanomedicines for the delivery of glucocorticoids and nucleic acids as potential alternatives in the treatment of rheumatoid arthritis.

  2020cites this paper
• Controlled Release Systems for DNA Delivery Controlled Release Systems for DNA Delivery

  2019cites this paper
• Polyethylenimine-based formulations for delivery of oligonucleotides.

  2019cites this paper
• Aerosolizable modified‐release particles of montelukast improve retention and availability of the drug in the lungs

  2017cites this paper
• Linear polyethylenimine as (multi) functional initiator for organocatalytic l-lactide polymerization.

  2015cites this paper
• Nanoparticle-Based Targeted Therapeutics in Head-And-Neck Cancer

  2015cites this paper
• PLGA microspheres encapsulating siRNA.

  2015cites this paper
• The use of ultrasonic atomization for encapsulation and other processes in food and pharmaceutical manufacturing

  2015cites this paper
• Nanoscale Particles for Lung Delivery of siRNA

  2014cites this paper
• Modulation of Polyplex Release from Biodegradable Microparticles through Poly(ethylenimine) Modification and Varying Loading Concentration

  2013cites this paper
• Novel PLGA microspheres for sustained delivery of antisense oligonucleotide

  2013cites this paper
• Intensifying the microencapsulation process: ultrasonic atomization as an innovative approach.

  2012cites this paper
• Engineered PLGA nano‐ and micro‐carriers for pulmonary delivery: challenges and promises

  2012cites this paper
• Nonviral Gene Delivery for Applications in Regenerative Medicine

  2012cites this paper
• PLGA microspheres encapsulating siRNA anti-TNFalpha: efficient RNAi-mediated treatment of arthritic joints.

  2012cites this paper
• Engineering Biomaterials for Regenerative Medicine: Novel Technologies for Clinical Applications

  2012cites this paper
• Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells

  2011cites this paper
• Rational design of polymeric siRNA delivery systems

  2011cites this paper
• Oligonucleotide delivery in cancer therapy

  2010cites this paper
• Inhibition of the EGFR with nanoparticles encapsulating antisense oligonucleotides of the EGFR enhances radiosensitivity in SCCVII cells

  2010cites this paper
• Synthesis of biodegradable polymer-mesoporous silica composite microspheres for DNA prime-protein boost vaccination.

  2010cites this paper
• Nasal delivery of antisense oligonucleotides: in vitro evaluation of a thiomer/glutathione microparticulate delivery system

  2010influential citation
• Fabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery.

  2010cites this paper
• Surface functionalisation of PLGA nanoparticles for gene silencing.

  2010cites this paper
• STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.

  2010cites this paper
• Inhibition of Ataxia-Telangiectasia Mutated by Antisense Oligonucleotide Nanoparticles Induces Radiosensitization of Head and Neck Squamous-Cell Carcinoma in Mice

  2009cites this paper
• THEMED SECTION: VECTOR DESIGN AND DRUG DELIVERY REVIEW Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA

  2009cites this paper
• Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA

  2009influential citation
• Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides

  2009cites this paper
• Polymeric nanoparticles for siRNA delivery and gene silencing.

  2009cites this paper
• Nano and Microtechnologies for the Delivery of Oligonucleotides with Gene Silencing Properties

  2009cites this paper
• Clusterin antisense complexed with chitosan for controlled intratumoral delivery.

  2008cites this paper
• Process considerations related to the microencapsulation of plasmid DNA via ultrasonic atomization

  2008influential citation
• Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation.

  2008cites this paper
• Dual-role self-assembling nanoplexes for efficient gene transfection and sustained gene delivery.

  2008cites this paper
• Surface modification of microspheres with steric stabilizing and cationic polymers for gene delivery.

  2008cites this paper
• Sustained release of complexed and naked DNA from polymer films.

  2008cites this paper
• LIPID-BASED NANO AND MICROTECHNOLOGIES FOR INTRAOCULAR AND LUNG DELIVERY OF POORLY STABLE AND/OR POORLY ABSORBED ACTIVE DRUGS

  2008cites this paper
• Microspheres of new alternating copolyesters derived from glycolic acid units for controlled drug release

  2008cites this paper
• Macroporous surface modified microparticles.

  2008cites this paper
• Effects of different cyclodextrins on the morphology, loading and release properties of poly (DL-lactide-co-glycolide)-microparticles containing the hypnotic agent etizolam

  2007cites this paper
• Protein release behavior from porous microparticle with lysozyme/hyaluronate ionic complex.

  2007cites this paper
• Release studies of naked DNA, polyplexes and lipoplexes from polymeric films

  2007cites this paper
• [Development of gene delivery system using PLGA nanospheres].

  2007cites this paper
• Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA.

  2006cites this paper
• Microspheres from new biodegradable poly(ester amide)s with different ratios of L- and D-alanine for controlled drug delivery

  2006cites this paper
• Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs.

  2006cites this paper
• Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery.

  2006cites this paper
• Preparation and characterization of PLGA nanospheres for the targeted delivery of NR2B-specific antisense oligonucleotides to the NMDA receptors in the brain

  2005cites this paper
• Enhanced intracellular uptake and inhibition of NF‐κB activation by decoy oligonucleotide released from PLGA microspheres

  2005cites this paper
• Controlled release of oligonucleotide/polyethyleneimine complexes from PLGA-based microspheres: potential of spray-drying technique

  2005cites this paper
• The Toxicological Study of CCNU Controlled Release Film In Vivo

  2004cites this paper
• Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids.

  2004cites this paper
• Gene delivery from polymer scaffolds for tissue engineering

  2004cites this paper
• Polymeric Delivery Systems for Biopharmaceuticals

  2004cites this paper
• Controlled release systems for DNA delivery.

  2004cites this paper
• Innovations in oligonucleotide drug delivery

  2003cites this paper
• Long-term release and improved intracellular penetration of oligonucleotide-polyethylenimine complexes entrapped in biodegradable microspheres.

  2003cites this paper
• Spectrophotometric determination of polyethylenimine in the presence of an oligonucleotide for the characterization of controlled release formulations.

  2003cites this paper
• Encapsulation and release of the hypnotic agent zolpidem from biodegradable polymer microparticles containing hydroxypropyl-beta-cyclodextrin.

  2003cites this paper
• Literature Alerts

  2003cites this paper
• A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes.

  2003cites this paper